Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
about
In vitro and in vivo activities of NS-718, a new lipid nanosphere incorporating amphotericin B, against Aspergillus fumigatusRodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis.Antifungal prophylaxis with itraconazole in neutropenic patients: pharmacological, microbiological and clinical aspects.
P2860
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@ast
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@en
type
label
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@ast
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@en
prefLabel
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@ast
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@en
P2093
P2860
P356
P1476
Efficacy of intravenous itraconazole against experimental pulmonary aspergillosis.
@en
P2093
Mitsutake K
Miyazaki HM
Miyazaki Y
P2860
P304
P356
10.1128/AAC.37.12.2762
P407
P577
1993-12-01T00:00:00Z